D&O cover gap review in Singapore: what the rules require

A D&O cover gap review in Singapore tests one specific question: does the group's directors and officers insurance actually respond to the exposure a director incurs under Singapore company law, or was the policy written for a different jurisdiction and simply extended by inclusion. Singapore requires at least one director ordinarily resident in the jurisdiction, and that requirement changes who is exposed, to what, and on what timetable. The review that answers this is not a reading of the policy wording alone; it is a comparison between what Singapore law imposes on a director personally and what the policy schedule actually covers.

A regional holding structure appoints a Singapore-resident individual to satisfy the local director requirement, renews the group D&O policy from the parent's home market without amendment, and assumes the local appointee is covered because the policy lists "all directors of subsidiaries." Six months later a creditor claim or a regulatory inquiry tests that assumption, and the schedule turns out to exclude liabilities arising under the law of jurisdictions where the insurer has no local licence to write cover. By then the appointment is already on the public register.

This page sets out what changes for that review once the jurisdiction is Singapore: the requirement that drives it, the register consequence that follows from acting on it, and the boundary of what this firm does and does not do in relation to the appointment itself.

What changes in Singapore

Singapore company law requires at least one director who is ordinarily resident in Singapore. This is a positive requirement, not a default that applies only in the absence of something else 01 - the company cannot be validly constituted or maintained without it. That single fact is the reason a D&O cover gap review in Singapore looks different from the same exercise run for a jurisdiction with no residency test: the person filling the role is very often not an executive of the group at all, and the policy drafted for the group's own officers was never underwritten with that person's exposure in mind.

Doing business in Singapore through a locally incorporated entity therefore creates a distinct category of insured person. A board resolution appointing a resident director is a routine item in the minute book, but the appointment terms attached to it decide whether that director's personal liability is matched by cover, or merely assumed to be. Singapore company law does not require the company to hold D&O insurance at all - there is no statutory mandate on this point - which means the gap, if one exists, is created entirely by how the group's own policy was drafted, not by any local insurance rule.

The local requirement or test that drives the work

The test applied in this review is narrow and factual: for each Singapore-resident director, does the current D&O policy extend to liabilities arising under Singapore law, and does it extend to that specific individual rather than to "directors of the group" as a defined class that may or may not include a locally appointed appointee. A policy schedule listing subsidiaries by name is not the same as a schedule confirming territorial scope for claims brought in Singapore, under Singapore law, before a Singapore forum. Groups regularly conflate the two.

A second element of the test follows directly from the residency requirement itself. Because Singapore law insists on a locally resident director as a matter of company law, not as a matter of convenience 01, that person's exposure is not incidental to the group's structure - it is a condition of the structure existing at all. Once the resident director is exposed personally under Singapore's director duties regime, the question of whether the group's cover follows that person is not a secondary matter for the annual renewal. It is fixed the day the appointment is lodged, and it remains fixed until the policy is amended, not until the appointment ends.

This is the point at which the review becomes irreversible in practical terms: once a resident director accepts the appointment under terms that assume cover which the policy schedule does not in fact provide, that exposure cannot be reversed retroactively by a later amendment to the policy. 02 A later amendment protects claims arising after it takes effect; it does not reach back to cover the period the director already served without matching cover.

The filing, register or forum consequence

Every appointment, resignation and change of particulars of a director in Singapore is lodged with the Accounting and Corporate Regulatory Authority, and the register it maintains is open to public search. 03 Once an appointment is filed, it becomes visible to counterparties, creditors and regulators on that public record; it is not withdrawn if the appointment turns out to have been made on the wrong assumptions about cover, only corrected going forward by a further filing recording a resignation or replacement. The appointment, and the period it covers, stays on the record regardless.

Beneficial ownership sits on a separate register. Singapore's Register of Registrable Controllers records the individuals who ultimately control a company, but that register is not open to public search; it is available only to the Accounting and Corporate Regulatory Authority and to specified public authorities. 04 That distinction matters to a D&O review because a director's own exposure is publicly visible from the moment of appointment, while the controller behind the structure is not - which is exactly why the resident director carries a personal exposure the ultimate owner does not share in the same way.

Before relying on any timetable, a group should have in front of it: the current register extract for each Singapore entity, the appointment letter or board resolution under which the resident director was engaged, the D&O policy schedule with its territorial and named-insured wording, and a note of when the policy was last amended to reflect a Singapore appointment.

• Current ACRA register extract for the entity
• The board resolution and director appointment terms on file
• The D&O policy schedule, territorial scope and named-insured clause
• Date the policy was last amended for the Singapore appointment

Read the Singapore jurisdiction brief for how the register interacts with minority shareholder claims, since a claim under those provisions is one of the routes by which a resident director's personal exposure is actually tested: minority shareholder remedies in Singapore.

What this service does not include in Singapore

This engagement does not include acting as, supplying, sourcing or arranging a director, secretary, nominee shareholder or trustee for a Singapore entity, and it does not include any activity for which a licence under Singapore's regime for corporate service providers is required. Arranging for a person outside the group to act as a director is itself a regulated activity in Singapore, and carrying it out without the required licence is an offence 05, so the boundary is not a matter of firm policy - it is a matter of what this firm is licensed to do. A firm that arranges directors without a licence, and an individual acting on its instructions, is exposed to sanction under the same regime 06, which is precisely the exposure a client engaging this firm is trying to avoid, not acquire.

What the review produces instead: a mapped statement of what Singapore's resident director requirement actually demands, a set of criteria against which the existing appointee's terms can be tested, a marked-up comparison between the D&O policy schedule and the exposure the appointment actually creates, and a written note of what has to change before the next renewal date to close the gap. None of that requires a licence this firm does not hold. Sourcing the person to fill the role, if the current appointee has to be replaced, sits with the client's own corporate service provider or the company's Singapore-licensed filing agent - see the comparable structure for the Abu Dhabi Global Market version of this review, which draws the same line: D&O cover gap review in the Abu Dhabi Global Market.

For groups running the same exercise across more than one common-law offshore centre, the comparison of how director liability itself is framed differs enough to change what the gap review is actually testing: compare director liability in the BVI and the DIFC.

Frequently asked questions

What happens if a D&O cover gap review in Singapore is not carried out?

The resident director continues to carry personal exposure under Singapore company law without confirmation that the group's policy responds to it. The gap is not visible until a claim is made, at which point the policy's actual wording, not the group's assumption about it, decides the outcome.

How often should this review be repeated?

At minimum on every D&O policy renewal and on every change of resident director, since both events reset the question of whether the named insureds and territorial scope still match who is actually exposed. A policy amendment made mid-term does not cover the period before it took effect.

Does this change for a foreign-owned company?

The residency requirement applies regardless of who owns the entity, so a wholly foreign-owned Singapore subsidiary needs a resident director on the same basis as a locally owned one. What often differs is the policy: a foreign parent's group D&O cover is more likely to have been drafted without Singapore's territorial exposure in mind.

What does the review require in practice?

The current register extract, the director appointment terms, the policy schedule and its territorial wording, and the date of the last amendment made for the Singapore appointment. Most of the work is comparing these documents against each other, not producing new ones.

Who inside the company is responsible for closing the gap once it is identified?

The board resolves to amend the policy or the appointment terms; it is not something the resident director can fix alone, since the director is usually the person exposed by the gap, not the person with authority over the group's insurance arrangements.

A group carrying a resident director in Singapore without having tested the policy schedule against that appointment is carrying an exposure it cannot see. The gap, once found, usually turns out to be a drafting problem rather than a coverage refusal - which is also why it is fixable, but only before the next claim, not after it.

Assess your director exposure

Write to info@hreithlaw.com with the jurisdiction and the structure.

See also what typically changes once a D&O cover gap review is complete, and start from the practice overview if the group has more than one Singapore entity: D&O cover gap review, practice overview.